• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以家庭为基础、多触发因素、多成分干预措施的经济价值,以环境为重点,减少哮喘发病率:社区指南系统评价。

Economic value of home-based, multi-trigger, multicomponent interventions with an environmental focus for reducing asthma morbidity a community guide systematic review.

机构信息

Air Pollution and Respiratory Health Branch, Division of Health Hazards and Health Effects, National Center for Environmental Health, CDC, Atlanta, Georgia 30341, USA.

出版信息

Am J Prev Med. 2011 Aug;41(2 Suppl 1):S33-47. doi: 10.1016/j.amepre.2011.05.011.

DOI:10.1016/j.amepre.2011.05.011
PMID:21767734
Abstract

CONTEXT

A recent systematic review of home-based, multi-trigger, multicomponent interventions with an environmental focus showed their effectiveness in reducing asthma morbidity among children and adolescents. These interventions included home visits by trained personnel to assess the level of and reduce adverse effects of indoor environmental pollutants, and educate households with an asthma client to reduce exposure to asthma triggers. The purpose of the present review is to identify economic values of these interventions and present ranges for the main economic outcomes (e.g., program costs, benefit-cost ratios, and incremental cost-effectiveness ratios).

EVIDENCE ACQUISITION

Using methods previously developed for Guide to Community Preventive Services economic reviews, a systematic review was conducted to evaluate the economic efficiency of home-based, multi-trigger, multicomponent interventions with an environmental focus to improve asthma-related morbidity outcomes. A total of 1551 studies were identified in the search period (1950 to June 2008), and 13 studies were included in this review. Program costs are reported for all included studies; cost-benefit results for three; and cost-effectiveness results for another three. Information on program cost was provided with varying degrees of completeness: six of the studies did not provide a list of components included in their program cost description (limited cost information), three studies provided a list of program cost components but not a cost per component (partial cost information), and four studies provided both a list of program cost components and costs per component (satisfactory cost information).

EVIDENCE SYNTHESIS

Program costs per participant per year ranged from $231-$14,858 (in 2007 U.S.$). The major factors affecting program cost, in addition to completeness, were the level of intensity of environmental remediation (minor, moderate, or major), type of educational component (environmental education or self-management), the professional status of the home visitor, and the frequency of visits by the home visitor. Benefit-cost ratios ranged from 5.3-14.0, implying that for every dollar spent on the intervention, the monetary value of the resulting benefits, such as averted medical costs or averted productivity losses, was $5.30-$14.00 (in 2007 U.S.$). The range in incremental cost-effectiveness ratios was $12-$57 (in 2007 U.S.$) per asthma symptom-free day, which means that these interventions achieved each additional symptom-free day for net costs varying from $12-$57.

CONCLUSIONS

The benefits from home-based, multi-trigger, multicomponent interventions with an environmental focus can match or even exceed their program costs. Based on cost-benefit and cost-effectiveness studies, the results of this review show that these programs provide a good value for dollars spent on the interventions.

摘要

背景

最近一项针对以家庭为基础、多触发因素、多成分且以环境为重点的干预措施的系统评价显示,这些干预措施可有效降低儿童和青少年的哮喘发病率。这些干预措施包括由经过培训的人员进行家访,以评估室内环境污染物的水平并减少其不良影响,并对有哮喘患者的家庭进行教育以减少哮喘诱因的暴露。本综述的目的是确定这些干预措施的经济价值,并介绍主要经济结果(例如,项目成本、成本效益比和增量成本效益比)的范围。

证据采集

使用先前为社区预防服务指南经济评价制定的方法,进行了一项系统评价,以评估以家庭为基础、多触发因素、多成分且以环境为重点的干预措施在改善与哮喘相关的发病率结果方面的经济效率。在搜索期间(1950 年至 2008 年 6 月)共确定了 1551 项研究,其中有 13 项研究被纳入本综述。所有纳入的研究均报告了项目成本;其中三项研究报告了成本效益结果;另有三项研究报告了成本效果结果。提供了项目成本信息,但完整程度不同:有六项研究没有提供项目成本描述中包含的组成部分清单(提供有限的成本信息),三项研究提供了项目成本组成部分清单但没有每个组成部分的成本(提供部分成本信息),四项研究同时提供了项目成本组成部分清单和每个组成部分的成本(提供满意的成本信息)。

证据综合

每位参与者每年的项目成本从 231 美元到 14858 美元不等(2007 年美国美元)。除了完整性之外,影响项目成本的主要因素还包括环境修复的强度(轻微、中度或重度)、教育组成部分的类型(环境教育或自我管理)、家访人员的专业地位以及家访人员的访问频率。成本效益比范围从 5.3 到 14.0,这意味着每花费 1 美元用于干预措施,干预措施所带来的经济价值(如避免的医疗费用或避免的生产力损失)为 5.30 美元到 14.00 美元(2007 年美国美元)。增量成本效益比的范围为 12 美元到 57 美元(2007 年美国美元)/哮喘无症状日,这意味着这些干预措施每获得一个额外的无症状日,其净成本从 12 美元到 57 美元不等。

结论

以家庭为基础、多触发因素、多成分且以环境为重点的干预措施的收益可以与其成本相匹配,甚至超过成本。基于成本效益和成本效果研究,本综述的结果表明,这些计划为干预措施的支出提供了很好的价值。

相似文献

1
Economic value of home-based, multi-trigger, multicomponent interventions with an environmental focus for reducing asthma morbidity a community guide systematic review.以家庭为基础、多触发因素、多成分干预措施的经济价值,以环境为重点,减少哮喘发病率:社区指南系统评价。
Am J Prev Med. 2011 Aug;41(2 Suppl 1):S33-47. doi: 10.1016/j.amepre.2011.05.011.
2
Effectiveness of home-based, multi-trigger, multicomponent interventions with an environmental focus for reducing asthma morbidity: a community guide systematic review.以家庭为基础、多触发因素、多组分且注重环境的干预措施在降低哮喘发病率方面的效果:社区指南系统评价。
Am J Prev Med. 2011 Aug;41(2 Suppl 1):S5-32. doi: 10.1016/j.amepre.2011.05.012.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Home-based educational interventions for children with asthma.针对哮喘儿童的家庭式教育干预措施。
Cochrane Database Syst Rev. 2025 Feb 6;2(2):CD008469. doi: 10.1002/14651858.CD008469.pub3.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.针对患者及护理人员的干预措施,以提高对镰状细胞病的认识及其相关并发症的识别能力。
Cochrane Database Syst Rev. 2016 Oct 6;10(10):CD011175. doi: 10.1002/14651858.CD011175.pub2.
9
The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.基于家庭的、由护士主导的老年人健康促进的临床效果和成本效益:系统评价。
Health Technol Assess. 2012;16(20):1-72. doi: 10.3310/hta16200.
10
Interventions to improve inhaler technique for people with asthma.改善哮喘患者吸入器使用技术的干预措施。
Cochrane Database Syst Rev. 2017 Mar 13;3(3):CD012286. doi: 10.1002/14651858.CD012286.pub2.

引用本文的文献

1
Prescriptions (Rx) for Prevention: Clinical Tools for Integrating Environmental Health into Pediatric Clinical Care.预防处方(Rx):将环境卫生纳入儿科临床护理的临床工具。
J Public Health Manag Pract. 2025;31(2):244-251. doi: 10.1097/PHH.0000000000002044. Epub 2024 Sep 9.
2
A qualitative study of perspectives on the acceptability and feasibility of "virtual home visits" for asthma.一项关于“虚拟家访”在哮喘方面的可接受性和可行性的观点的定性研究。
BMC Public Health. 2023 Dec 20;23(1):2546. doi: 10.1186/s12889-023-17485-8.
3
Assessing asthma self-management education among US children with current asthma, Asthma Call-back Survey (ACBS) 2015-2017.
评估美国当前患有哮喘的儿童的哮喘自我管理教育情况,哮喘电话回访调查(ACBS),2015-2017 年。
J Asthma. 2023 Oct;60(10):1918-1925. doi: 10.1080/02770903.2023.2200842. Epub 2023 Apr 20.
4
A Cost-Effectiveness Analysis of a Community Health Worker Led Asthma Education Program in South Texas.南德克萨斯州由社区卫生工作者主导的哮喘教育项目的成本效益分析。
J Asthma Allergy. 2022 May 4;15:547-556. doi: 10.2147/JAA.S351141. eCollection 2022.
5
Housing and asthma disparities.住房与哮喘差异。
J Allergy Clin Immunol. 2021 Nov;148(5):1121-1129. doi: 10.1016/j.jaci.2021.09.023. Epub 2021 Sep 29.
6
Barriers to antigen detection and avoidance in chronic hypersensitivity pneumonitis in the United States.美国慢性过敏性肺炎中抗原检测和避免的障碍。
Respir Res. 2021 Aug 10;22(1):225. doi: 10.1186/s12931-021-01817-6.
7
Development of an Asthma Home-Visit Training Program for Community Health Workers and Their Supervisors in Washington State.为华盛顿州的社区卫生工作者及其主管制定哮喘家访培训计划。
Front Public Health. 2021 Jun 25;9:674843. doi: 10.3389/fpubh.2021.674843. eCollection 2021.
8
Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations.环境暴露物在间质性肺疾病患者中的识别和处理:证据回顾和实际考虑。
Chest. 2021 Jul;160(1):219-230. doi: 10.1016/j.chest.2021.02.021. Epub 2021 Feb 18.
9
Indoor Air Quality at Home-An Economic Analysis.家庭室内空气质量分析——经济视角
Int J Environ Res Public Health. 2021 Feb 9;18(4):1679. doi: 10.3390/ijerph18041679.
10
Sustainability of residential environmental interventions and health outcomes in the elderly.老年人居住环境干预措施的可持续性与健康结果
Asthma Res Pract. 2020 Nov 2;6(1):13. doi: 10.1186/s40733-020-00066-6.